Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Deep Learning Powered AI Algorithms Improve Skin Cancer Diagnostic Accuracy

By LabMedica International staff writers
Posted on 16 Apr 2024

Artificial intelligence (AI) algorithms are increasingly being utilized in various clinical settings, such as dermatology. More...

These algorithms are developed by training a computer with hundreds of thousands or millions of images of various skin conditions, each labeled with details like the diagnosis and patient outcomes. Through a process known as deep learning, the computer learns to identify patterns in the images that are indicative of specific skin diseases, including cancers. Once sufficiently trained, the algorithm can suggest potential diagnoses based on new images of a patient’s skin. However, these algorithms do not operate in isolation; they are used under the supervision of clinicians who evaluate the patient, make their own diagnostic assessments, and decide whether to follow the algorithm's recommendations.

Now, a new study led by researchers at Stanford Medicine (Stanford, CA, USA) has found that AI algorithms, which utilize deep learning, can enhance the accuracy of diagnosing skin cancers. This benefit extends to dermatologists, though the improvement is more pronounced for non-dermatologists. The study analyzed 12 research papers that documented over 67,000 evaluations of possible skin cancers by various medical practitioners, both with and without AI assistance. Findings indicated that healthcare practitioners without AI support accurately diagnosed approximately 75% of actual skin cancer cases and correctly identified about 81.5% of non-cancerous conditions that resembled cancer. The performance of healthcare practitioners improved when they used AI to assist with diagnoses. Their sensitivity increased to about 81.1% and their specificity to 86.1%.

Although these improvements might appear modest, they are crucial for correctly diagnosing patients who are either mistakenly told they do not have cancer when they do, or incorrectly informed they have cancer when they do not. The analysis further revealed that medical students, nurse practitioners, and primary care physicians gained the most from AI assistance, with average improvements of approximately 13 points in sensitivity and 11 points in specificity. While dermatologists and dermatology residents already showed higher overall accuracy, their diagnostic performance also saw gains in sensitivity and specificity with AI assistance. The researchers are now looking to further explore the potential and challenges of integrating AI tools into healthcare, particularly focusing on how physicians' and patients' perceptions and attitudes towards AI could affect its adoption.

“Previous studies have focused on how AI performs when compared with physicians,” said postdoctoral scholar Jiyeong Kim, PhD. “Our study compared physicians working without AI assistance with physicians using AI when diagnosing skin cancers.”

Related Links:
Stanford Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings show that measuring a broader panel of blood proteins can improve Alzheimer\'s disease staging (Image Credit: iStock)

Multi-Protein Blood Test Improves Staging of Alzheimer’s Disease

Alzheimer’s disease begins years before dementia develops, as amyloid plaques and tau pathology progressively damage neurons. Diagnosis has traditionally relied on cognitive decline, while biomarker testing... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.